Mark A Glickman's Net Worth
Estimate Recalculated Nov 1, 2024 09:52AM EST
Who is Mark A Glickman
Mark A Glickman has an estimated net worth of $1.9 Million. This is based on reported shares across multiple companies, which include Esperion Therapeutics, Inc., Aralez Pharmaceuticals Inc., TherapeuticsMD, Inc., NeuroBo Pharmaceuticals, Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, and OSCIENT PHARMACEUTICALS CORP.
SEC CIK
Mark A Glickman's CIK is 0001441461
Past Insider Trading and Trends
2014 was Mark A Glickman's most active year for acquiring shares with 8 total transactions. Mark A Glickman's most active month to acquire stocks was the month of January. 2014 was Mark A Glickman's most active year for disposing of shares, totalling 8 transactions. Mark A Glickman's most active month to dispose stocks was the month of December. 2014 saw Mark A Glickman paying a total of $837,250.00 for 127,325 shares, this is the most they've acquired in one year. In 2014 Mark A Glickman cashed out on 91,780 shares for a total of $1,666,870.23, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
